Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Amortization of Deferred Charges: 2023-2024

Historic Amortization of Deferred Charges for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $83,000.

  • Camp4 Therapeutics' Amortization of Deferred Charges fell 94.74% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $32,000, marking a year-over-year decrease of 67.35%. This contributed to the annual value of $83,000 for FY2024, which is 9.78% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Amortization of Deferred Charges stood at $83,000 for FY2024, which was down 9.78% from $92,000 recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Amortization of Deferred Charges ranged from a high of $92,000 in FY2023 and a low of $83,000 during FY2024.
  • Its 2-year average for Amortization of Deferred Charges is $87,500, with a median of $87,500 in 2023.
  • Data for Camp4 Therapeutics' Amortization of Deferred Charges shows a maximum YoY fell of 9.78% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Amortization of Deferred Charges (Yearly) stood at $92,000 in 2023, then dropped by 9.78% to $83,000 in 2024.